Cargando…
Pathways for aberrant angiogenesis in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease. Although the specific mechanisms that dictate its biological aggressiveness are not clearly established, it is characterized by a variety of molecular alterations as well as by the overexpression of mitogenic and angiogenic growth fac...
Autor principal: | Korc, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149422/ https://www.ncbi.nlm.nih.gov/pubmed/12556241 http://dx.doi.org/10.1186/1476-4598-2-8 |
Ejemplares similares
-
Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways
por: Bararia, Akash, et al.
Publicado: (2023) -
A Kras(G12D)-Driven Genetic Mouse Model of Pancreatic Cancer Requires Glypican-1 for Efficient Proliferation and Angiogenesis
por: Whipple, Chery A., et al.
Publicado: (2011) -
Aberrant angiogenesis: The gateway to diabetic complications
por: Kota, Sunil K., et al.
Publicado: (2012) -
TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis
por: Gore, Jesse, et al.
Publicado: (2015) -
Beyond Kras: MYC Rules in Pancreatic Cancer
por: Korc, Murray
Publicado: (2018)